How do you manage patients who are Hepatitis B core antibody positive/surface antigen negative and starting a biologic DMARD (other than rituximab)?
Answer from: at Academic Institution
According to the 2015 American College of Rheumatology Guidelines, a patient with natural immunity to Hepatitis B (Core & Surface Antibody-positive; Antigen-negative, normal liver function tests) can be treated as any other patient. However, monitoring of viral load is recommended "regularly" at...
Comments
at Cleveland Clinic We rely heavily on the AASLD guidelines which are ...
at The University of Tennessee Health Science Center/West Cancer Center AGA 2015 Guidelines are somewhat different from AA...
We rely heavily on the AASLD guidelines which are ...
AGA 2015 Guidelines are somewhat different from AA...